SUBSCRIBE
SUBSCRIBE
Genetown

Novel Biologics Thwart Recurrent C. Diff, University of Massachusetts Medical School Study

June 4, 2009 | 
1 min read

MedPage Today -- CHICAGO, June 3 -- Two investigational monoclonal antibody drugs, added to standard antibiotics, prevented recurrent Clostridium difficile infections in a randomized trial, researchers reported.

MORE ON THIS TOPIC
Job Trends
Massachusetts’ Life Sciences Job Growth Slows, but 10-Year Outlook Remains Strong: Report
June 12, 2024
 · 
4 min read
 · 
Angela Gabriel
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
Pictured: Collage of Sarepta Therapeutics, DNA, and an IV bag
FDA
Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy
May 7, 2024
 · 
4 min read
 · 
Tyler Patchen